VVector Bio was founded to contribute to filling the current gap for complex molecule drug manufacturing and support Research & Development and clinical studies of novel biological products. The company provides expert services in process development (upstream and downstream), cell line development, gene therapy viral vector design and production (Adeno-associated virus (AAV), lentivirus), virus and viral vector-based vaccines and recombinant protein production. Our manufacturing technology allows high production yields in HEK-293 suspension cells and baculovirus-insect cell systems. VVector Bio headquarter is located in Montreal, Canada within McGill University campus.
VVECTOR BIO, Bridging Research and Clinic
2020 VVECTOR BIO. All Rights Reserved